Evidence map›Paper›PMID 16675950›Full record

ArticleThe EMBO journal2006

Opposing effects of the UV lesion repair protein XPA and UV bypass polymerase eta on ATR checkpoint signaling.

Ryan D Bomgarden, Patrick J Lupardus, Deena V Soni, Muh-Ching Yee, James M Ford, Karlene A Cimprich

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 87 citations in OpenAlex.

  1. The 6-4 photoproduct is the trigger of UV-induced replication blockage and ATR activation.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ryan D BomgardenDepartment of Molecular Pharmacology, Stanford University, Stanford, CA 94305-5174, USA.
Patrick J Lupardus
Deena V Soni
Muh-Ching Yee
James M Ford
Karlene A Cimprich
Stanford University · US

Funding

Role of ATR in the DNA Damage ResponseR01GM062193 · NIGMS · STANFORD UNIVERSITY · PI CIMPRICH, KARLENE A · 2002 to 2006
$1.4M
NIGMS NIH HHS GM62193NIGMS NIH HHS R01 GM062193
6 · The paper itself

Abstract

An essential component of the ATR (ataxia telangiectasia-mutated and Rad3-related)-activating structure is single-stranded DNA. It has been suggested that nucleotide excision repair (NER) can lead to activation of ATR by generating such a signal, and in yeast, DNA damage processing through the NER pathway is necessary for checkpoint activation during G1. We show here that ultraviolet (UV) radiation-induced ATR signaling is compromised in XPA-deficient human cells during S phase, as shown by defects in ATRIP (ATR-interacting protein) translocation to sites of UV damage, UV-induced phosphorylation of Chk1 and UV-induced replication protein A phosphorylation and chromatin binding. However, ATR signaling was not compromised in XPC-, CSB-, XPF- and XPG-deficient cells. These results indicate that damage processing is not necessary for ATR-mediated S-phase checkpoint activation and that the lesion recognition function of XPA may be sufficient. In contrast, XP-V cells deficient in the UV bypass polymerase eta exhibited enhanced ATR signaling. Taken together, these results suggest that lesion bypass and not lesion repair may raise the level of UV damage that can be tolerated before checkpoint activation, and that XPA plays a critical role in this activation.

Indexed as

DNA RepairAdaptor Proteins, Signal TransducingAnimalsAtaxia Telangiectasia Mutated ProteinsCell CycleCell Cycle ProteinsCell LineCheckpoint Kinase 1DNADNA-Binding ProteinsDNA DamageDNA-Directed DNA PolymeraseDNA HelicasesDNA Repair EnzymesExodeoxyribonucleasesHumansAdaptor Proteins, Signal TransducingAtaxia Telangiectasia Mutated ProteinsATRIP protein, humanATR protein, humanCell Cycle ProteinsCheckpoint Kinase 1CHEK1 protein, humanChek1 protein, mouseChek1 protein, XenopusDNADNA-Binding ProteinsDNA-Directed DNA PolymeraseDNA HelicasesDNA Repair EnzymesERCC6 protein, humanErcc6 protein, mouseExodeoxyribonucleasesPhosphoproteinsPoly-ADP-Ribose Binding ProteinsProtein KinasesProtein Serine-Threonine KinasesRad30 proteinthree prime repair exonuclease 1Xenopus ProteinsXeroderma Pigmentosum Group A ProteinXPA protein, humanY-Family DNA Polymerases

Identifiers

PMID16675950
PMCPMC1478198
OpenAlexW2062564859

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.